Literature DB >> 7587629

The role of CD44 splice variants in human metastatic cancer.

J Sleeman1, J Moll, L Sherman, P Dall, S T Pals, H Ponta, P Herrlich.   

Abstract

The large family of CD44 splice variants are likely to serve multiple functions in the embryo and in the adult organism. This is reflected in their complex patterns of expression. In molecular terms these functions are largely unknown. Certain splice variants (CD44v) can promote the metastatic behaviour of cancer cells. In human colon and breast cancer the presence of epitopes encoded by exon v6 on primary resected tumour material indicates poor prognosis. Metastasis-promoting splice variants differ from those that seem not to have a role in the induction of metastasis by the formation of homomultimeric complexes in the plasma membrane of cells. This may increase their affinity to ligands such as hyaluronate. The affinity can be further regulated over a range from low to very high by cell-specific modification. The fact that CD44v epitopes are found on normal epithelial cells such as skin, cervical epithelium and bladder enforces cautious evaluation of the significance of CD44v expression in human cancer. Nevertheless, certain epitopes can serve as tools in early diagnosis of certain cancers and will facilitate the development of specific targeted therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587629     DOI: 10.1002/9780470514719.ch11

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  9 in total

1.  CD44 variant exons in leukemia and lymphoma.

Authors:  Elif Akisik; Sevil Bavbek; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 2.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

Review 3.  The normal structure and function of CD44 and its role in neoplasia.

Authors:  R J Sneath; D C Mangham
Journal:  Mol Pathol       Date:  1998-08

4.  Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.

Authors:  M J Gardner; J B Catterall; L M Jones; G A Turner
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

5.  Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.

Authors:  Suvi Tuulia Avoranta; Eija Annika Korkeila; Kari Juhani Syrjänen; Seppo Olavi Pyrhönen; Jari Toivo Tapio Sundström
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

6.  Expression of CD44s in human colorectal cancer.

Authors:  Mousa Khoursheed; T C Mathew; R R Makar; L Sonia; H Abul; S Asfar; H Al-Sayer; H M Dashti; A Al-Bader
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

7.  Role of VEGF and CD44v6 in differentiating benign from malignant ascites.

Authors:  Wei-Guo Dong; Xiao-Min Sun; Bao-Ping Yu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

8.  CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation.

Authors:  B S Mitchell; A Whitehouse; P Prehm; B Delpech; U Schumacher
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

9.  CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.

Authors:  Lili Wang; Qin Liu; Dongliang Lin; Maode Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.